Skip to content

Evaluation of Sheng Canruo 's acupuncture manipulation in the treatment of old based on infrared thermal imager

Evaluation of Sheng Canruo 's acupuncture manipulation in the treatment of old based on infrared thermal imager

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002012
Enrollment
Unknown
Registered
2025-10-22
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral facial palsy

Interventions

test team:Sheng 's needling method

Sponsors

jiangsu province hospital of chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
68 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.In line with the diagnostic criteria for peripheral facial paralysis, the patient 's cognitive ability is good, and the patient voluntarily signs an ' informed consent form '. 2.Age = 65 years and = 85 years ; 3.Unilateral onset ; 4.First onset, and the course of disease within 14 days ;

Exclusion criteria

Exclusion criteria: 1.Facial paralysis caused by surgery, trauma or secondary to tumors, otitis media and other diseases ; 2.Patients with bleeding tendency diseases such as leukemia ; 3.Combined with severe cardiovascular and cerebrovascular, respiratory system, liver, kidney, diabetic neuropathy and other basic diseases and mental disorders. Those who need drug control ; 4.Serious fainting, unable to tolerate acupuncture treatment ; 5.Acupuncture local skin has the risk of damage or infection 6.Suspected or had a history of alcohol and drug abuse. 7.Other lesions that, according to the researcher 's judgment, are likely to reduce or complicate the likelihood of enrollment, such as frequent work environment Changes are likely to cause loss of follow-up. 8. allergic constitution, such as two or more drugs or food allergy history ; or known to be allergic to the ingredients of this drug. 9. Patients participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
House-Brackmann facial nerve function rating scale ( H-B scale );

Secondary

MeasureTime frame
infrared thermal imaging;electromyogram;

Countries

China

Contacts

Public ContactSheng Yan

jiangsu province hospital of chinese medicine

915535274@qq.com13851570898

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026